Evidence map›Paper›PMID 27918575›Full record

Observational studyPloS one2016

High Serum Adiponectin Level Is a Risk Factor for Anemia in Japanese Men: A Prospective Observational Study of 1,029 Japanese Subjects.

Kei Kohno, Hiroto Narimatsu, Yosuke Shiono, Ikuko Suzuki, Yuichi Kato, Ri Sho, Katsumi Otani, Kenichi Ishizawa, Hidetoshi Yamashita, Isao Kubota and 4 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Kei KohnoDepartment of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Yamagata University School of Medicine, Yamagata City, Yamagata, Japan.
Hiroto NarimatsuCancer Prevention and Control Division, Kanagawa Cancer Center Research Institute, Yokohama City, Kanagawa, Japan.
Yosuke ShionoDepartment of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Yamagata University School of Medicine, Yamagata City, Yamagata, Japan.
Ikuko SuzukiDepartment of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Yamagata University School of Medicine, Yamagata City, Yamagata, Japan.
Yuichi KatoDepartment of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Yamagata University School of Medicine, Yamagata City, Yamagata, Japan.
Ri ShoDepartment of Public Health, Yamagata University Graduate School of Medicine, Yamagata City, Yamagata, Japan.
Katsumi OtaniDepartment of Public Health, Yamagata University Graduate School of Medicine, Yamagata City, Yamagata, Japan.
Kenichi IshizawaDepartment of Hematology and Cell Therapy, Yamagata University School of Medicine, Yamagata City, Yamagata, Japan.
Hidetoshi YamashitaDepartment of Ophthalmology and Visual Sciences, Yamagata University School of Medicine, Yamagata City, Yamagata, Japan.
Isao KubotaFirst Department of Internal Medicine, Yamagata University School of Medicine, Yamagata City, Yamagata, Japan.
Yoshiyuki UenoSecond Department of Internal Medicine, Yamagata University School of Medicine, Yamagata City, Yamagata, Japan.
Takeo KatoDepartment of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Yamagata University School of Medicine, Yamagata City, Yamagata, Japan.
Akira FukaoDepartment of Public Health, Yamagata University Graduate School of Medicine, Yamagata City, Yamagata, Japan.
Takamasa KayamaDepartment of Neurosurgery, Yamagata University School of Medicine, Yamagata City, Yamagata, Japan.
Yamagata University · JPKanagawa Cancer Center

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Erythroid abnormalities including anemia and polycythemia are often observed in the general clinical setting. Because recent studies reported that adiponectin negatively affects hematopoiesis, we performed a prospective observational study to assess the relationship between anemia and adiponectin, as well as other parameters, in 1029 Japanese subjects (477 men and 552 women) 40 years of age and older. Body measurements, blood tests, and nutrition intake studies were performed at baseline, and 5 to 7 years later (follow-up). Hemoglobin (Hb) and hematocrit (Hct) levels in men with high serum adiponectin levels were lower at follow-up than at baseline. Multiple regression analysis showed that age, body mass index, adiponectin, and glutamic-pyruvic transaminase were significantly associated with erythroid-related variables (red blood cells, Hb, and Hct) in both men and women (P <0.05). In a logistic regression analysis, adiponectin, fasting blood glucose, and β-natriuretic peptide were significant risk factors for anemia in men, and blood urea nitrogen and amylase were significant risk factors in women. Physical features and nutrient intake were not risk factors for anemia. Our study demonstrates, both clinically and epidemiologically, that a high serum adiponectin level decreases the amounts of erythroid-related variables and is a risk factor for anemia in Japanese men.

Indexed as

AdiponectinAdultAgedAged, 80 and overAlanine TransaminaseAmylasesAnemiaAsian PeopleBlood GlucoseBlood Urea NitrogenFemaleFollow-Up StudiesHematocritHemoglobinsHumansMaleAdiponectinAlanine TransaminaseAmylasesBlood GlucoseHemoglobins

Identifiers

PMID27918575
PMCPMC5137881
OpenAlexW2560185899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.